CBS 2019
CBSMD教育中心
English

充血性心力衰竭

科研文章

荐读文献

Frequency, predictors, and prognosis of ejection fraction improvement in heart failure: an echocardiogram-based registry study Association Between Functional Impairment and Medication Burden in Adults with Heart Failure The Hospital Readmissions Reduction Program Nationwide Perspectives and Recommendations: A JACC: Heart Failure Position Paper Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction The prevalence and importance of frailty in heart failure with reduced ejection fraction - an analysis of PARADIGM-HF and ATMOSPHERE Percutaneous Atriotomy for Levoatrial–to–Coronary Sinus Shunting in Symptomatic Heart Failure: First-in-Human Experience Empagliflozin Increases Cardiac Energy Production in Diabetes - Novel Translational Insights Into the Heart Failure Benefits of SGLT2 Inhibitors Is Acute heart failure a distinctive disorder? An analysis from BIOSTAT-CHF In acute HF and iron deficiency, IV ferric carboxymaltose reduced HF hospitalizations, but not CV death, at 1 y Age-Related Characteristics and Outcomes of Patients With Heart Failure With Preserved Ejection Fraction

Review Articlev.10(8); 2021 Aug

JOURNAL:Cells. Article Link

Effect of SGLT2-Inhibitors on Epicardial Adipose Tissue: A Meta-Analysis

W Masson, A Lavalle-Cobo, JP Nogueira et al. Keywords: SGLT2-i; epicardial adipose tissue

Full Text PDF